Journals / Turkish Journal of Pediatrics / 1998 / Cilt: 40 - Sayı: 3

Pro - inflammatory cytokines, lymphocyte subsets and intravenous immunoglobulin therapy in guillain - barre syndrome

Pages
357–363
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We studied pro-inflammatory cytokines (interleukin-2, interleukin-1

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Both cell-mediated immunity and humoral factors are involved in the pathogenesis of Guillain-Barre syndrome (GBS).
📊
Key Findings & Data:Intravenous immunoglobulin (IVIG) has been reported to be a practical, effective and safe treatment in childhood GBS, although the mode of action of IVIG remains uncertain.
💡
Conclusion & Impact:We studied pro-inflammatory cytokines (interleukin-2, interleukin-1
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Both cell-mediated immunity and humoral factors are involved in the pathogenesis of Guillain-Barre syndrome (GBS). Intravenous immunoglobulin (IVIG) has been reported to be a practical, effective and safe treatment in childhood GBS, although the mode of action of IVIG remains uncertain. We studied pro-inflammatory cytokines (interleukin-2, interleukin-1

🔖

Cite This Article

TEKGÜL, H., TÜTÜNCÜOĞLU, S., ÇAĞLAYAN, S., KÜTÜKÇÜLER, N. (2022). Pro - inflammatory cytokines, lymphocyte subsets and intravenous immunoglobulin therapy in guillain - barre syndrome. Turkish Journal of Pediatrics, Cilt: 40 - Sayı: 3, 357–363. https://ajindex.com/articles/613550

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...